Efficacy of Memantine, Donepezil, or Their Association in Moderate-Severe Alzheimer's Disease: A Review of Clinical Trials

Background. Acetylcholinesterase (AChE)/cholinesterase (ChE) inhibitors (Is) and memantine are licensed for symptomatic treatment of mild-moderate and moderate-severe forms of Alzheimer's disease (AD), respectively. High doses of the AChE-I donepezil were licensed in the USA for moderate-severe...

Descripción completa

Detalles Bibliográficos
Autores principales: Molino, Ivana, Colucci, Luisa, Fasanaro, Angiola M., Traini, Enea, Amenta, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3830825/
https://www.ncbi.nlm.nih.gov/pubmed/24288512
http://dx.doi.org/10.1155/2013/925702

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3830825/
https://www.ncbi.nlm.nih.gov/pubmed/24288512
http://dx.doi.org/10.1155/2013/925702

Ejemplares similares